New Classifications of Five Distinct “Sleep” Profi... ...
Science in the Age of AI | AI for Science Forum...
Ask the Heart Doctor | Heart Valve Disease and Sur...
High-speed imaging tracks live brain cell activity...
NAD⁺ restores memory in Alzheimer's disease models...
Mark Cuban: A Master Disrupter for American Health...
Teen girls facing the most adversity showed the biggest gain...
September 15,2026
Specialized imaging reveals hormone-driven brain changes...
September 14,2026
Submillimeter MRI reveals brain hubs that guide risky decisi...
September 12,2026
Risk of herpes zoster among breast cancer survivors in Japan...
September 11,2026
Three proteins help organs tailor shared circadian clock to ...
September 10,2026
Should you worry about melatonin and heart failure? The evid...
December 02,2025
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
GOSH BRC Showcase 2025 - Genomic medicine...
Can a twice-a-year shot help end the HIV...
Announcement of the 2025 Nobel Prize in ...
Reprogramming Stem Cells Could Cure Type...
Why MDMA did NOT get FDA approval...
More News
How common genetic alterations cause kidney cancer

How common genetic alterations cause kidney cancer

byUniversity of HelsinkiChromatin level interaction between the renal lineage factor PAX8 and oncogenic HIF2A in ccRCC. a,b, Pooled CRISPR–Cas9 loss-of-function screen results of ccRCC cell line
World medicine December 16,2023
How common genetic alterations cause kidney cancer

How common genetic alterations cause kidney cancer

byUniversity of HelsinkiChromatin level interaction between the renal lineage factor PAX8 and oncogenic HIF2A in ccRCC. a,b, Pooled CRISPR–Cas9 loss-of-function screen results of ccRCC cell line
World medicine December 16,2023
More accurate prediction of cancer risk in individuals with Li-Fraumeni syndrome

More accurate prediction of cancer risk in individuals with Li-Fraumeni syndrome

by Medizinische Hochschule HannoverSpectrum of TP53 germline variants and statistically significant genotype-phenotype correlations. Colored spheres refer to different patients harboring the correspon
World medicine December 16,2023
More accurate prediction of cancer risk in individuals with Li-Fraumeni syndrome

More accurate prediction of cancer risk in individuals with Li-Fraumeni syndrome

by Medizinische Hochschule HannoverSpectrum of TP53 germline variants and statistically significant genotype-phenotype correlations. Colored spheres refer to different patients harboring the correspon
World medicine December 16,2023
Long-term benefit of combining chemotherapy and radiotherapy in bladder cancer

Long-term benefit of combining chemotherapy and radiotherapy in bladder cancer

byInstitute of Cancer ResearchImage of a mouse bladder after surgery to remove a tumour. Credit:Frank C. MariniGiving people with bladder cancer chemotherapy and radiotherapy at the same t
World medicine December 16,2023
Long-term benefit of combining chemotherapy and radiotherapy in bladder cancer

Long-term benefit of combining chemotherapy and radiotherapy in bladder cancer

byInstitute of Cancer ResearchImage of a mouse bladder after surgery to remove a tumour. Credit:Frank C. MariniGiving people with bladder cancer chemotherapy and radiotherapy at the same t
World medicine December 16,2023
A better roadmap for beating deadly leukemia

A better roadmap for beating deadly leukemia

by Joe Rojas-Burke,Oregon Health & Science UniversityGraphical abstract. Credit:Cancer Cell(2022). DOI: 10.1016/j.ccell.2022.07.002Acute myeloid leukemia, or AML, is the most com
World medicine December 16,2023
A better roadmap for beating deadly leukemia

A better roadmap for beating deadly leukemia

by Joe Rojas-Burke,Oregon Health & Science UniversityGraphical abstract. Credit:Cancer Cell(2022). DOI: 10.1016/j.ccell.2022.07.002Acute myeloid leukemia, or AML, is the most com
World medicine December 16,2023
Survey finds uneven training in cannabis therapy among cannabis dispensary staff

Survey finds uneven training in cannabis therapy among cannabis dispensary staff

byDana-Farber Cancer InstituteCredit: Pixabay/CC0 Public DomainWith research suggesting that many patients with cancer are using cannabis for medical purposes—and oncology teams tending to offer
World medicine December 16,2023
Survey finds uneven training in cannabis therapy among cannabis dispensary staff

Survey finds uneven training in cannabis therapy among cannabis dispensary staff

byDana-Farber Cancer InstituteCredit: Pixabay/CC0 Public DomainWith research suggesting that many patients with cancer are using cannabis for medical purposes—and oncology teams tending to offer
World medicine December 16,2023
HER2-low metastatic breast cancer patients report preserved quality of life with trastuzumab deruxtecan treatment

HER2-low metastatic breast cancer patients report preserved quality of life with trastuzumab deruxtecan treatment

byUniversity of Texas M. D. Anderson Cancer CenterCredit: Unsplash/CC0 Public DomainPatients who received trastuzumab deruxtecan (T-DXd) for human epidermal growth factor receptor 2 (HER2)-low m
World medicine December 16,2023
HER2-low metastatic breast cancer patients report preserved quality of life with trastuzumab deruxtecan treatment

HER2-low metastatic breast cancer patients report preserved quality of life with trastuzumab deruxtecan treatment

byUniversity of Texas M. D. Anderson Cancer CenterCredit: Unsplash/CC0 Public DomainPatients who received trastuzumab deruxtecan (T-DXd) for human epidermal growth factor receptor 2 (HER2)-low m
World medicine December 16,2023
Empowering childhood cancer survivors to engage in physical activity

Empowering childhood cancer survivors to engage in physical activity

byUniversity of New South WalesCredit: Pixabay/CC0 Public DomainAbout 750 children are diagnosed with cancer in Australia each year. Thankfully, advancements in treatments have led to rising sur
World medicine December 16,2023
Empowering childhood cancer survivors to engage in physical activity

Empowering childhood cancer survivors to engage in physical activity

byUniversity of New South WalesCredit: Pixabay/CC0 Public DomainAbout 750 children are diagnosed with cancer in Australia each year. Thankfully, advancements in treatments have led to rising sur
World medicine December 16,2023
Steepest annual rise in advanced cervical cancer in US among White women

Steepest annual rise in advanced cervical cancer in US among White women

byBritish Medical JournalCredit: Unsplash/CC0 Public DomainThe steepest annual rise in new cases of advanced womb (cervical) cancer in the US is among White women, who are significantly less lik
World medicine December 16,2023
Steepest annual rise in advanced cervical cancer in US among White women

Steepest annual rise in advanced cervical cancer in US among White women

byBritish Medical JournalCredit: Unsplash/CC0 Public DomainThe steepest annual rise in new cases of advanced womb (cervical) cancer in the US is among White women, who are significantly less lik
World medicine December 16,2023
Harnessing the immune system to fight cancer

Harnessing the immune system to fight cancer

by Madeleine Turner,Whitehead Institute for Biomedical ResearchCredit: Gretchen Ertl/ Whitehead InstituteSometimes research takes scientists to unexpected places, even alpaca farms. Tobiloba Oni
World medicine December 16,2023
Harnessing the immune system to fight cancer

Harnessing the immune system to fight cancer

by Madeleine Turner,Whitehead Institute for Biomedical ResearchCredit: Gretchen Ertl/ Whitehead InstituteSometimes research takes scientists to unexpected places, even alpaca farms. Tobiloba Oni
World medicine December 16,2023
Pralsetinib achieves tissue-agnostic benefits for patients with RET gene fusions

Pralsetinib achieves tissue-agnostic benefits for patients with RET gene fusions

byUniversity of Texas M. D. Anderson Cancer CenterCredit: Unsplash/CC0 Public DomainThe highly selective RET inhibitor pralsetinib was well-tolerated and demonstrated robust, durable responses i
World medicine December 16,2023
Pralsetinib achieves tissue-agnostic benefits for patients with RET gene fusions

Pralsetinib achieves tissue-agnostic benefits for patients with RET gene fusions

byUniversity of Texas M. D. Anderson Cancer CenterCredit: Unsplash/CC0 Public DomainThe highly selective RET inhibitor pralsetinib was well-tolerated and demonstrated robust, durable responses i
World medicine December 16,2023
More News
Week’s Top
Podcasts
... Health spending has been rising across rich countries with different systems ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... At what age do people experience depression for the first time? Depression can affect people over long periods of their lives. Some people experience this condition continuously, while for others, it occu...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com